[HTML][HTML] Bedaquiline resistance in patients with drug-resistant tuberculosis in Cape Town, South Africa: a retrospective longitudinal cohort study
Background Bedaquiline is a life-saving tuberculosis drug undergoing global scale-up.
People at risk of weak tuberculosis drug regimens are a priority for novel drug access …
People at risk of weak tuberculosis drug regimens are a priority for novel drug access …
Bedaquiline resistance in patients with drug-resistant tuberculosis in Cape Town, South Africa: a retrospective longitudinal cohort study
B Derendinger, A Dippenaar, M de Vos, S Huo… - The Lancet …, 2023 - escholarship.org
BackgroundBedaquiline is a life-saving tuberculosis drug undergoing global scale-up.
People at risk of weak tuberculosis drug regimens are a priority for novel drug access …
People at risk of weak tuberculosis drug regimens are a priority for novel drug access …
[PDF][PDF] Bedaquiline resistance in patients with drug-resistant tuberculosis in Cape Town, South Africa: a retrospective longitudinal cohort study
B Derendinger, A Dippenaar, M de Vos, S Huo… - 2023 - researchgate.net
Background Bedaquiline is a life-saving tuberculosis drug undergoing global scale-up.
People at risk of weak tuberculosis drug regimens are a priority for novel drug access …
People at risk of weak tuberculosis drug regimens are a priority for novel drug access …
Bedaquiline resistance in patients with drug-resistant tuberculosis in Cape Town, South Africa: a retrospective cohort
B Derendinger, A Dippenaar, M de Vos… - Lancet …, 2023 - repository.uantwerpen.be
Background Bedaquiline is a life-saving tuberculosis drug undergoing global scale-up.
People at risk of weak tuberculosis drug regimens are a priority for novel drug access …
People at risk of weak tuberculosis drug regimens are a priority for novel drug access …
Bedaquiline resistance in patients with drug-resistant tuberculosis in Cape Town, South Africa: a retrospective longitudinal cohort study
B Derendinger, A Dippenaar, M de Vos… - Lancet …, 2023 - scienceportal.msf.org
BACKGROUND Bedaquiline is a life-saving tuberculosis drug undergoing global scale-up.
People at risk of weak tuberculosis drug regimens are a priority for novel drug access …
People at risk of weak tuberculosis drug regimens are a priority for novel drug access …
Bedaquiline resistance in patients with drug-resistant tuberculosis in Cape Town, South Africa: a retrospective longitudinal cohort study
B Derendinger, A Dippenaar, M de Vos… - The Lancet …, 2023 - pubmed.ncbi.nlm.nih.gov
Background Bedaquiline is a life-saving tuberculosis drug undergoing global scale-up.
People at risk of weak tuberculosis drug regimens are a priority for novel drug access …
People at risk of weak tuberculosis drug regimens are a priority for novel drug access …
[PDF][PDF] Bedaquiline resistance in patients with drug-resistant tuberculosis in Cape Town, South Africa: a retrospective longitudinal cohort study
B Derendinger, A Dippenaar, M de Vos, S Huo… - 2023 - api.scienceportal.msf.org
Background Bedaquiline is a life-saving tuberculosis drug undergoing global scale-up.
People at risk of weak tuberculosis drug regimens are a priority for novel drug access …
People at risk of weak tuberculosis drug regimens are a priority for novel drug access …
[HTML][HTML] Bedaquiline resistance in patients with drug-resistant tuberculosis in Cape Town, South Africa: a retrospective longitudinal cohort study
B Derendinger, A Dippenaar, M de Vos, S Huo… - The Lancet Microbe, 2023 - Elsevier
Background Bedaquiline is a life-saving tuberculosis drug undergoing global scale-up.
People at risk of weak tuberculosis drug regimens are a priority for novel drug access …
People at risk of weak tuberculosis drug regimens are a priority for novel drug access …
Bedaquiline resistance in patients with drug-resistant tuberculosis in Cape Town, South Africa: a retrospective longitudinal cohort study.
B Derendinger, A Dippenaar, M de Vos, S Huo… - The Lancet …, 2023 - europepmc.org
Background Bedaquiline is a life-saving tuberculosis drug undergoing global scale-up.
People at risk of weak tuberculosis drug regimens are a priority for novel drug access …
People at risk of weak tuberculosis drug regimens are a priority for novel drug access …
[PDF][PDF] Bedaquiline resistance in patients with drug-resistant tuberculosis in Cape Town, South Africa: a retrospective longitudinal cohort study
B Derendinger, A Dippenaar, M de Vos, S Huo… - 2023 - alosatb.org
Background Bedaquiline is a life-saving tuberculosis drug undergoing global scale-up.
People at risk of weak tuberculosis drug regimens are a priority for novel drug access …
People at risk of weak tuberculosis drug regimens are a priority for novel drug access …